Billets de Michelle Dawson

Billet publié sur Twitter/X le 22/11/2011 23:10

Retour aux billets Billet précédent Billet suivant
Twitter/X Essai clinique clinicaltrials.gov Question posée par Dawson dans le billet Lien intégré au billet Termes sur l’autisme
Ouvrir le billet original

Infos sur le lien intégré au billet

Essai clinique

Andrew Zimmerman, Johns Hopkins University (2011). Sulforaphane-rich Broccoli Sprout Extract for Autism. ClinicalTrials.gov. Andrew Zimmerman.

Plus d’infos

Liens cités structurés

1 ressource citée

Essai clinique Récupéré Publication clinicaltrials.gov

Andrew Zimmerman, Johns Hopkins University (2011). Sulforaphane-rich Broccoli Sprout Extract for Autism. ClinicalTrials.gov. Andrew Zimmerman.

Date de publication
2011
Identifiant
NCT01474993
Auteurs
Andrew Zimmerman, Johns Hopkins University
Source
ClinicalTrials.gov
Type de référence
clinical_trial
Éditeur
Andrew Zimmerman
Source de métadonnées
clinicaltrials.gov

Résumé

The primary objectives of this study are to answer whether there is evidence of measurable effects on social responsiveness (primary outcome) and other behavioral symptoms after treatment of autistic male adolescents and adults with orally administered sulforaphane-rich Broccoli Sprout Extract (efficacy). The secondary objectives of this study are to answer whether treatment of male adolescents and adults with autism using orally administered sulforaphane-rich Broccoli Sprout Extract within a specified dose range is safe (toxicity); treatment with sulforaphane-rich Broccoli Sprout Extract is well tolerated (side effects and adverse events); key cellular biomarkers support the hypothesized mechanisms (proof of principle).

Ouvrir la source